Versant Venture Management, LLC Long-Term Concentrated

CIK: 0001560009 · Show all filings

Period: Q2 2020 (← Previous) (Next →)

Filing Date: Jul 20, 2020

Total Value ($000): $696,065,245 (100.0% shares, 0.0% debt)

Holdings (12)

CRSP CRISPR Therapeutics AG 44.2%

Value ($000) $307,413,373 Shares 4,183,064 Est. Cost $40.26 Unrealized +45.2%

— Adverum Biotechnologies, Inc. 21.0%

Value ($000) $146,241,265 Shares 7,003,892 Est. Cost $9770.00 Unrealized —

— Aprea Therapeutics, Inc. 10.3%

Value ($000) $71,907,001 Shares 1,854,229 Est. Cost $38780.00 Unrealized —

— Akero Therapeutics, Inc. 7.6%

Value ($000) $52,717,114 Shares 2,115,454 Est. Cost $21200.00 Unrealized —

CRNX Crinetics Pharmaceuticals, Inc. 5.1%

Value ($000) $35,576,392 Shares 2,030,616 Est. Cost $17.05 Unrealized 0.0%

VCYT Veracyte, Inc. 4.5%

Value ($000) $31,220,041 Shares 1,205,407 Est. Cost $11.03 Unrealized +125.9%

— Gritstone Oncology, Inc. 3.0%

Value ($000) $20,603,449 Shares 3,102,929 Est. Cost $11140.00 Unrealized —

OCUL Ocular Therapeutix, Inc. 2.7%

Value ($000) $18,454,145 Shares 2,215,384 Est. Cost $20.09 Unrealized -67.0%

— IVERIC bio, Inc. 1.3%

Value ($000) $8,797,036 Shares 1,724,909 Est. Cost $5100.00 Unrealized —

— CymaBay Therapeutics, Inc. 0.3%

Value ($000) $1,897,697 Shares 543,753 Est. Cost $9871.60 Unrealized —

— Clovis Oncology, Inc. 0.1%

Value ($000) $687,521 Shares 101,855 Est. Cost $56000.00 Unrealized —

— Second Sight Medical Products, Inc. 0.1%

Value ($000) $550,211 Shares 561,612 Est. Cost $1210.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CRSP	CRISPR Therapeutics AG	4,183,064	$307,413,373	44.2%	$40.26	+45.2%	Common Stock	H17182108
—	Adverum Biotechnologies, Inc.	7,003,892	$146,241,265	21.0%	$9770.00	—	Common Stock	00773U108
—	Aprea Therapeutics, Inc.	1,854,229	$71,907,001	10.3%	$38780.00	—	Common Stock	03836J102
—	Akero Therapeutics, Inc.	2,115,454	$52,717,114	7.6%	$21200.00	—	Common Stock	00973Y108
CRNX	Crinetics Pharmaceuticals, Inc.	2,030,616	$35,576,392	5.1%	$17.05	0.0%	Common Stock	22663K107
VCYT	Veracyte, Inc.	1,205,407	$31,220,041	4.5%	$11.03	+125.9%	Common Stock	92337F107
—	Gritstone Oncology, Inc.	3,102,929	$20,603,449	3.0%	$11140.00	—	Common Stock	39868T105
OCUL	Ocular Therapeutix, Inc.	2,215,384	$18,454,145	2.7%	$20.09	-67.0%	Common Stock	67576A100
—	IVERIC bio, Inc.	1,724,909	$8,797,036	1.3%	$5100.00	—	Common Stock	46583P102
—	CymaBay Therapeutics, Inc.	543,753	$1,897,697	0.3%	$9871.60	—	Common Stock	23257D103
—	Clovis Oncology, Inc.	101,855	$687,521	0.1%	$56000.00	—	Common Stock	189464100
—	Second Sight Medical Products, Inc.	561,612	$550,211	0.1%	$1210.00	—	Common Stock	81362J100